Weiqiang Zhao
- Genetics top 0.5%
- Pathology and Forensic Medicine top 0.5%
- Molecular Biology top 10%
- Oncology top 2%
- Hematology top 1%
- Co-authors
- John C. ByrdNyla A. HeeremaAmy J. JohnsonKristie A. BlumJan A. BurgerWilliam G. WierdaSteven CoutréSusan O’Brien
- Topics
- Chronic Lymphocytic Leukemia Research (27 papers)Lymphoma Diagnosis and Treatment (20 papers)Acute Myeloid Leukemia Research (17 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Weiqiang Zhao
113 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Genetics 1.6k
- Pathology and Forensic Medicine 1.3k
- Molecular Biology 1.2k
- Oncology 1.1k
- Hematology 975
Countries citing papers authored by Weiqiang Zhao
This map shows the geographic impact of Weiqiang Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqiang Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqiang Zhao more than expected).
Fields of papers citing papers by Weiqiang Zhao
This network shows the impact of papers produced by Weiqiang Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqiang Zhao. The network helps show where Weiqiang Zhao may publish in the future.
Co-authorship network of co-authors of Weiqiang Zhao
This figure shows the co-authorship network connecting the top 25 collaborators of Weiqiang Zhao. A scholar is included among the top collaborators of Weiqiang Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqiang Zhao. Weiqiang Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 11 | |
| 5 | 4 | |
| 6 | 10 | |
| 7 | 126 | |
| 8 | 22 | |
| 9 | 19 | |
| 10 | 26 | |
| 11 | 7 | |
| 12 | 47 | |
| 13 | E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Groupbreakdown → | 317 |
| 14 | 11 | |
| 15 | 5 | |
| 16 | 28 | |
| 17 | 12 | |
| 18 | 43 | |
| 19 | 3 | |
| 20 | 26 |
About Weiqiang Zhao
Weiqiang Zhao is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 119 papers that have together received 4.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (27 papers), Lymphoma Diagnosis and Treatment (20 papers) and Acute Myeloid Leukemia Research (17 papers). The work is most often cited by research in Genetics (1.6k citations), Hematology (975 citations) and Otorhinolaryngology (381 citations). Weiqiang Zhao has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include John C. Byrd, Nyla A. Heerema, Amy J. Johnson, Kristie A. Blum, Jan A. Burger, William G. Wierda, Steven Coutré, Susan O’Brien, Richard R. Furman and Jeffrey A. Jones. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.